Synaptic lipid signaling: Significance of polyunsaturated fatty acids and platelet-activating factor

Journal of Lipid Research

Volumn 44, Issue 12, 2003, Pages 2221-2233

  Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diacylglycerols; Docosahexaenoic acid; Endocannabinoids; Lipidomics; Long term potentiation; Phospholipases A2; Photoreceptors; Prostaglandins

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; ARACHIDONOYLDIACYLGLYCEROL; CANNABINOID; CYCLOOXYGENASE 2; CYTOKINE; DIACYLGLYCEROL DERIVATIVE; DOCOSAHEXAENOIC ACID; ION CHANNEL; LIPID; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN MEMBRANE; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR MEMBRANE; MEMBRANE DEPOLARIZATION; MICROGLIA; MICROVASCULATURE; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; FATTY ACIDS, UNSATURATED; HUMANS; LIPID METABOLISM; NERVOUS SYSTEM; NEURONAL PLASTICITY; PLATELET ACTIVATING FACTOR; SYNAPTIC TRANSMISSION;

EID: 0345861750     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R300013-JLR200     Document Type: Review

References (152)

1. Chandrasekharan, N. V., H. Dai, K. L. Roos, N. K. Evanson, J. Tomsik, T. S. Elton, and D. L. Simmons. 2002. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. USA. 99: 13926-13931.
2. Bazan, N. G., and R. J. Flower. 2002. Lipids signals in pain control. Nature. 420: 135-138.
3. Yamagata, K., K. I. Andreasson, W. E. Kaufmann, C. A. Barnes, and P. F. Worley. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11: 371-386.
4. Kaufmann, W. E., P. F. Worley, J. Pegg, M. Bremer, and P. Isakson. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 93: 2317-2321.
5. Chen, C., J. C. Magee, and N. G. Bazan. 2002. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87: 2851-2857.
6. 2. J. Biol. Chem. 274: 11660-11666.
7. Katto, K., G. D. Clark, N. G. Bazan, and C. F. Zorumski. 1994. Platelet activating factor as a potential retrograde messenger in Ca1 hippocampal long-term potentiation. Nature. 367: 175-179.
8. 2-induced sensitization of rat sensory neurons in vitro. J. Neurosci. 18: 10345-10355.
9. Ingram, S. L., and J. T. Williams. 1996. Modulation of the hyperpolarization-activated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons. J. Physiol. 492: 97-106.
10. Nicol, G. D., M. R. Vasko, and A. R. Evans. 1997. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J. Neurophysiol. 77: 167-176.
11. Bi, G. Q., and M. M. Poo. 2001. Synaptic modification by correlated activity: Hebb's postulate revisited. Annu. Rev. Neurosci. 24: 139-166.
12. Koester, H., and B. Sakmann. 1998. Calcium dynamics in single spines during coincident pre- and postsynaptic activity depend on relative timing of back-propagating action potentials and sub-threshold excitatory postsynaptic potentials. Proc. Natl. Acad. Sci. USA. 95: 9596-9601.
13. Magee, J. C., and D. Johnston. 1997. A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. Science. 275: 209-213.
14. Markram, H., J. Lübke, M. Frotscher, and B. Sakmann. 1997. Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science. 275: 213-215.
15. Taylor, A. L., and S. J. Hewett. 2002. Potassium-evoked glutamate release liberates arachidonic acid from cortical neurons. J. Biol. Chem. 277: 43881-43887.
16. Birkle, D. L., and N. G. Bazan. 1984. Effects of K+ depolarization on the synthesis of prostaglandins and hydroxyeicosatetra(5,8,11,14) enoic acids (HETE) in the rat retina. Evidence for esterification of 12-HETE in lipids. Biochim. Biophys. Acta. 795: 564-573.
17. Birkle, D. L., and N. G. Bazan. 1987. Effect of bicuculline-induced status epilepticus on prostaglandins and hydroxyeicosatetraenoic acids in rat brain subcellular fractions. J. Neurochem. 48: 1768-1778.
18. Lothman, E. W., and J. M. Williamson. 1993. Rapid kindling with recurrent hippocampal seizures. Epilepsy Res. 14: 209-220.
19. Tu, B., and N. G. Bazan. 2003. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol. 179: 167-175.
20. Bazan, N. G., M. G. Packard, L. Teather, and G. Allan. 1997. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30: 225-231.
21. Bosetti, F., G. R. Weerasinghe, T. A. Rosenberger, and S. I. Rapoport. 2003. Valproic acid down regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J. Neurochem. 85: 690-696.
22. Basselin, M., L. Chang, R. Seemann, J. M. Bell, and S. I. Rapoport. 2003. Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats. J. Neurochem. 85: 1553-1562.
23. O'Banion, M. K., J. C. Miller, J. W. Chang, M. D. Kaplan, and P. D. Coleman. 1996. Interleukin-1 β induces prostaglandin G/H synthase 2 (cyclooxygenases-2) in primary murine astrocyte cultures. J. Neurochem. 66: 2532-2540.
24. Nedergaard, M. 1994. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 263: 1768-1771.
25. Bezzi, P., G. Carmignoto, L. Pasti, S. Vesce, D. Rossi, B. L. Rizzini, T. Pozzan, and A. Volterra. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391: 281-285.
26. Anderson, C. M., and M. Nedergaard. 2003. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci. 26: 340-344.
27. Zonta, M., M. C. Angulo, S. Gobbo, B. Rosengarten, K. A. Hossmann, T. Pozzan, and G. Carmignoto. 2003. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6: 43-50.
28. Harder, D. R., N. J. Alkayed, A. R. Lange, D. Gebremedhin, and R. J. Ronian. 1998. Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke. 29: 229-234.
29. Xu, J., A. Y. Sun, and G. Y. Sun. 2003. Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). Free Radic. Biol. Med. 34: 1531-1543.
30. Xu, J., Y. I. Weng, A. Simonyi, B. W. Krugh, Z. Liao, G. A. Weisman, G. Y. Sun, and A. Simoni. 2002. Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83: 259-270.
31. Tong, W., D. Shah, J. Xu, J. A. Diehl, A. Hans, M. Hannink, and G. Y. Sun. 1999. Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC). J. Mol. Neurosci. 12: 89-99.
32. Pettitt, T. R., and M. J. O. Wakelam. 1999. Diacylglycerol kinase epsilon, but not zeta, selectively removes polyunsaturated diacylglycerol, inducing altered protein kinase C distribution in vivo. J. Biol. Chem. 274: 36181-36186.
33. Hodgkin, M. N., T. R. Pettitt, A. Martin, R. H. Michell, A. J. Pemberton, and M. J. Wakelam. 1998. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23: 200-204.
34. Bazan, N. G. 1970. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta. 218: 1-10.
35. Aveldaño, M. I., and N. G. Bazan. 1975. Rapid production of diacylglycerols enriched in arachidonate and stearate during early brain ischemia. J. Neurochem. 25: 919-920.
36. Aveldaño de Caldironi, M. I., and N. G. Bazan. 1979. Alpha-Methyl-p-Tyrosine inhibits the production of free arachidonic acid and diacylglycerols in brain after a single electroconvulsive shock. Neurochem. Res. 4: 213-221.
37. Prescott, S. M., and P. W. Majerus. 1981. The fatty acid composition of phosphatidylinositol from thrombin-stimulated human platelets. J. Biol. Chem. 256: 579-582.
38. Rodriguez de Turco, E. B., W. Tang, M. K. Tophan, F. Sakane, V. L. Marcheselli, C. Chen, A. Taketomi, S. M. Prescott, and N. G. Bazan. 2001. Diacylglycerol kinase e regulates seizure susceptibility and long-term potentiation through arachidonoyl-inositol lipid signaling. Proc. Natl. Acad. Sci. USA. 98: 4740-4745.
39. Petralia, R. S., Y. X. Wang, S. Singh, C. Wu, L. Shi, J. Wei, and R. J. Wenthold. 1997. A monoclonal antibody shows discrete cellular and subcellular localizations of mGluR1 alpha metabotrophic glutamate receptors. J. Chem. Neuroanat. 13: 77-93.
40. Berthele, A., D. J. Laurie, S. Platzer, W. Zieglgansberger, T. R. Tolle, and B. Sommer. 1998. Differential expression of rat and human type 1 metabotrophic glutamate receptor splice variant messenger RNAs. Neuroscience. 85: 733-749.
41. Egertova, M., D. K. Giang, B. F. Cravatt, and M. R. Elphick. 1998. A new perspective on cannabinoid signaling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. Lond. B. Biol. Sci. 265: 2081-2085.
42. Tsou, K., M. Nogueron, S. Muthian, M. Sanudo-Pena, C. Hillard, D. Deutsch, and J. Walker. 1998. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci. Lett. 254: 137-140.
43. Willoughby K. A., S. F. Moore, B. R. Martin, and E. F. Ellis. 1997. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282: 243-247.
44. Ohno-Shosaku, T., T. Maejima, and M. Kano. 2001. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron. 29: 729-738.
45. Wilson, R. I., and R. A. Nicoll. 2001. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature. 410: 588-592.
46. Wilson, R. I., and R. A. Nicoll. 2002. Endocannabinoid signaling in the brain. Science. 296: 678-682.
47. Katona, I., B. Sperlagh, A. Sik, A. Kafalvi, E. S. Vizi, K. Mackie, and T. F. Freoud. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19: 4544-4558.
48. Clement, A. B., E. G. Hawkins, A. H. Lichtman, and B. F. Cravatt. 2003. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J. Neurosci. 23: 3916-3923.
49. Rosenberger, T. A., N. E. Villacreses, M. A. Contreras, J. V. Bonventre, and S. I. Rapoport. 2003. Brain lipid metabolism in the cPLA2 knockout mouse. J. Lipid Res. 44: 109-117.
50. Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
51. Molloy, G. Y., M. Rattray, and R. J. Williams. 1998. Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci. Lett. 258: 139-142.
52. Dennis, E. A. 1994. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269: 13057-13060.
53. Bonventre, J. V., Z. Huang, M. R. Taher, E. O'Leary, E. Li, M. A. Moskowitz, and A. Saperstein. 1997. Reduced fertility and post-ischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390: 622-625.
54. Qu, Y., L. Chang, J. Klaff, A. Balbo, and S. I. Rapoport. 2003. Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimenthoxy-4-iodophenyl-2-aminopropane (DOI). Neuropsychopharmacology. 28: 244-252.
55. Lambeau, G., J. Barhanin, H. Schweitz, J. Qar, and M. Lazdunski. 1989. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J. Biol. Chem. 264: 11503-11510.
56. Lambeau, G., A. Schmid-Alliana, M. Lazdunski, and J. Barhanin. 1990. Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle. J. Biol. Chem. 265: 9526-9532.
57. Lambeau, G., P. Ancian, J. Barhanin, and M. Lazdunski. 1994. Cloning and expression of a membrane receptor for secretory phospholipases A2. J. Biol. Chem. 269: 1575-1578.
58. Lambeau, G., P. Ancian, J-P. Nicolas, S. H. W. Beiboer, D. Moinier, H. Verheij, and M. Lazdunski. 1995. Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors. J. Biol. Chem. 270: 5534-5540.
59. Kolko, M., M. A. DeCoster, E. B. Rodriguez de Turco, and N. G. Bazan. 1996. Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J. Biol. Chem. 271: 32722-32728.
60. 2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. Neurosci. Lett. 338: 164-168.
61. 2 potentiates glutamate-induced rat striatal neuronal cell death in vivo. Neurosci. Lett. 274: 167-170.
62. 2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J. Neurosci. Res. 67: 634-645.
63. Matsuzawa, A., M. Makoto, G. Atsumi, K. Imal, P. Prados, K. Inoue, and I. Kudo. 1996. Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem. J. 318: 701-709.
64. Beuckmann, C. T., W. C. Gordon, Y. Kanaoka, N. Eguchi, V. L. Marcheselli, D. Y. Gerashchenko, Y. Urade, O. Hayaishi, and N. G. Bazan. 1996. Lipocalin-type prostaglandin D synthase (β-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix. J. Neurosci. 16: 6119-6124.
65. Geraschenko, D. Y., C. T. Beuckmann, V. L. Marcheselli, W. C. Gordon, Y. Kanaoka, N. Eguchi, Y. Urade, O. Hayaishi, and N. G. Bazan. 1998. Localization of lipocalin-type prostaglandin D synthase (β-trace) in iris, ciliary body and eye fluids. Invest. Ophthalmol. Vis. Sci. 39: 198-203.
66. Geraschenko, D. Y., C. T. Beuckmann, Y. Kanaoka, N. Eguchi, W. C. Gordon, Y. Urade, N. G. Bazan, and O. Hayaishi. 1998. Dominant expression of rat prostanoid DP receptor mRNA in leptomeninges, inner segments of photoreceptor cells, iris epithelium, and ciliary processes. J. Neurochem. 71: 937-945.
67. Scott, B. L., and N. G. Bazan. 1989. Membrane docosahexanoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA. 86: 2903-2907.
68. Li, J., M. G. Wetzel, and P.J. O'Brien. 1992. Transport of n-3 fatty acids from the intestine to the retina in rats. J. Lipid Res. 33: 539-548.
69. Wang, N., and R. E. Anderson. 1993a. Synthesis of docosahexaenoic acid by retina and retinal pigment epithelium. Biochemistry. 32: 13703-13709.
70. Wang, N., and R. E. Anderson. 1993b. Transport of 22:6n-3 in plasma and uptake into retinal pigment epithelium and retina. Exp. Eye Res. 57: 225-233.
71. Martin, R. E., E. B. Rodriguez de Turco, and N. G. Bazan. 1994. Developmental maturation of hepatic n-3 polyunsaturated fatty acid metabolism: supply of docosahexaenoic acid to retina and brain. J. Nutr. Biochem. 5: 151-160.
72. Gordon, W. C., and N. G. Bazan. 1993. Visualization of [3H]docosahexaenoic acid trafficking through photoreceptors and retinal pigment epithelium bv electron microscopic autoradiography. Invest. Ophthalmol. Vis. Sci. 57: 2402-2411.
73. Bazan, N. G., W. C. Gordon, and E. B Rodriguez de Turco. 1992. The uptake, metabolism and conservation of docosahexaenoic acid (22:6-3) in brain and retina: alterations in liver and retina 22:6 metabolism during inherited progressive retinal degeneration. In Essential Fatty Acids and Eicosanoids: Invited Papers from the Third International Congress. A. Sinclair and R. Gibson, editors. American Oil Chemists' Society, Champaign, IL. 107-115.
74. 3H-docosahexaenoyl]phosphatidate to rhodopsin during in vivo labeling of frog retinal rod outer segments. Neurochem. Res. 25: 695-703.
75. Gordon, W. C., E. B. Rodriguez de Turco, and N. B. Bazan. 1992. Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr. Eye Res. 11: 73-83.
76. Bazan, N. G., E. B. Rodriguez de Turco, and W. C Gordon. 1994. Docosahexaenoic acid supply to the retina and its conservation in photoreceptor cells by active retinal pigment epithelium-mediated recycling. In Fatty Acids and Lipids: Biological Aspects. C. Galli, A. P. Simopoulos, and E. Tremoli, editors. Karger, Basel. 120-123.
77. Aveldaño, M. I. 1998. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry. 27: 1229-1239.
78. Bazan, N. G. 1990. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In Nutrition and the Brain. R. J. Wurtman and J. J. Wurtman, editors. Raven Press, New York. 1-24.
79. Bush, R. A., A. Malnoë, C. E. Remé, and T. P. Williams. 1994. Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina. Invest. Ophthalmol. Vis. Sci. 35: 91-100.
80. Brown, M. F. 1994. Modulation of rhodopsin function by properties of the membrane bilayer. Chem. Phys. Lipids. 73: 159-180.
81. Converse, C. A., H. M. Hammer, C. J. Packard, and J. Shephard. 1983. Plasma lipid abnormalities in retinitis pigmentosa and related conditions. Trans. Ophthalmol. Soc. U. K. 103: 508-512.
82. Anderson, R. E., M. B. Maude, R. S. Lewis, D. A. Newsome, and G. A. Fishman. 1987. Abnormal plasma levels of polyunsaturated fatty acid in autosomal dominant retinitis pigmentosa. Exp. Eye Res. 44: 155-159.
83. Gong, J., B. Rosner, D. G. Rees, E. L. Berson, C. A. Weigel-Di-Franco, and E. J. Schaefer. 1992. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 33: 2596-2602.
84. Hoffman, D. R., and D. G. Birch. 1998. Omega 3 fatty acid status in patients with retinitis pigmentosa. World Rev. Nutr. Diet. 83: 52-60.
85. Bazan, N. G., and E. B. Rodriguez de Turco. 1996. Alterations in plasma lipoproteins and DHA transport in progressive rod-cone degeneration (prcd). Retinal Degeneration and Regeneration, Proceedings of an International Symposium in Kanazawa, Japan. 1995.
86. Maude, M. B., E. O. Anderson, and R. E. Anderson. 1999. Polyunsaturated fatty acids are lower in blood lipids of Usher's type 1 but not Usher's type II. Invest. Ophthalmol. Vis. Sci. 39: 2164-2166.
87. Anderson, R. E., M. B. Maude, R. A. Alvarez, G. Acland, and G. D. Aguirre. 1999. A hypothesis to explain the reduced blood levels of docosahexaenoic acid in inherited retinal degenerations caused by mutations in genes encoding retina-specific proteins. Lipids. 34: S235-S237.
88. Aguirre, G. D., G. M. Acland, M. B. Maude, and R. E. Anderson. 1997. Diets enriched in docosahexaenoic acid fail to correct progressive rod-cone degeneration (prcd) phenotype. Invest. Ophthalmol. Vis. Sci. 38: 2387-2407.
89. Chen, H., J. Ray, V. Scarpino, G. M. Acland, G. D. Aguiree, and R. E. Anderson. 1999. Synthesis and release of docosahexaenoic acid by the RPE cells of prcd-affected dogs. Invest. Ophthalmol. Vis. Sci. 40: 2418-2422.
90. Nourooz-Zadeh, J., E. H. C. Liu, E. E. Anggard, and B. Halliwell. 1998. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid. Biochem. Biophys. Res. Commun. 242: 338-344.
91. Roberts II, L. J., T. J. Montine, W. R. Markesbery, A. R. Tappert, P. Hardy, S. Chemtob, W. D. Dettbarn, and J. D. Morrow. 1998. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273: 13605-13612.
92. Morrow, J. D., K. E. Hill, R. F. Burk, M. Tarek, T. M. Nammour, K. F. Badr, and J. L. Robert. 1990. A series of prostaglandin F2-like compounds are produced in vivo in human by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87: 9383-9387.
93. Nourooz-Zadeh, J., E. H. C. Liu, B. Yhlen, E. E. Anggard, and B. Halliwell. 1999. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J. Neurochem. 72: 734-740.
94. Bazan, N. G., D. L. Birkle, and T. S. Reddy. 1984. Docosahexaenoic acid (22:6, n 3) is metabolized to lipoxygenase reaction products in the retina. Biochem. Biophys. Res. Commun. 125: 741-747.
95. Marcheselli, V. L., S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, and N. G. Bazan. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278: 43807-43817.
96. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, and G. Mirick. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196: 1025-1037.
97. Serhan, C. N., C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2: nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192: 1197-1204.
98. Hong, S., K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. J. Biol. Chem. 278: 14677-14687.
99. Arai, A., and G. Lynch. 1992. Antagonists of the platelet-activating factor receptor block long-term potentiation in hippocampal slices. Eur. J. Neurosci. 4: 411-419.
100. Clark, G. D., L. T. Happel, C. F. Zorumski, and N. G. Bazan. 1992. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron. 9: 1211-1216.
101. Wieraszko, A., G. Li, E. Kornecki, M. V. Hogan, and Y. H. Ehrlich. 1993. Long-term potential in the hippocampus induced by platelet-activating factor. Neuron. 10: 553-557.
102. Bito, H., M. Nakamura, Z. Honda, T. Izumi, T. Iwatsubo, Y. Seyama, A. Ogura, Y. Kudo, and T. Shimizu. 1992. Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. Neuron. 9: 285-294.
103. Arai, H., H. Koizumi, J. Aoki, and K. Inoue. 2002. Platelet-activating factor acetylhydrolase (PAF-AH). J Biochem. 131: 635-640.
104. Bazan, N. G. 1995. Inflammation: a signal terminator. Nature. 374: 501-502.
105. Bazan, N. G., and G. Allan. 1988. Platelet-activating factor and other bioactive lipids. In Cerebrovascular Disease, Pathophysiology, Diagnosis and Management. M. D. Ginsberg and J. Bogousslavsky, editors. Blackwell Science Publishers, Malden, MA. 532-555.
106. Bussolino, P., F. Gremo, C. Tetta, G. Pescarmona, and G. Camussi. 1986. Production of platelet-activating factor by chick retina. J. Biol. Chem. 261: 16502-16508.
107. Bussolino, F., S. Torelli, E. Stefanini, and F. Gremo. 1989. Platelet-activating factor production occurs through stimulation of cholinergic and dopaminergic receptors in the chick retina. J. Lipid Med. 1: 283-288.
108. Kornecki, E., and Y. H. Ehrlich. 1988. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science. 240: 1792-1794.
109. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
110. Williams, J. H., M. L. Errington, M. A. Lynch, and T. V. P. Bliss. 1989. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature. 341: 739-742.
111. O'Dell, T. J., R. D. Hawkins, E. R. Kandel, and O. Arancio. 1991. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA. 88: 11285-11289.
112. Kato, K., K. Uruno, K. Saito, and H. Kato, 1991. Both arachidonic acid and 1-oleoyl-2-acetyl glycerol in low magnesium solution induce long-term potentiation in hippocampal CA1 neurons in vitro. Brain Res. 563: 94-100.
113. Izquierdo, I., C. Fin, P. K. Schmitz, R. C. Da Silva, D. Jerusalinsky, J. A. Quillfeldt, M. B. G. Ferreira, J. H. Medina, and N. G. Bazan. 1995. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task. Proc. Natl. Acad. Sci. USA. 92: 5047-5051.
114. Jerusalinsky, D., C. Fin, J. A. Quillfelot, C. F. Beatriz, P. K. Schmitz, R. C. DaSilva, R. Walz, N. G. Bazan, J. H. Medina, and I. Izquierdo. 1994. Effects of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. Behav. Neural Biol. 62: 1-3.
115. Packard, M. G., L. Teather, and N. G. Bazan. 1996. Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory. Neurobiol. Learn. Mem. 66: 176-182.
116. Bazan, N. G., M. G. Packard, L. Teather, and G. Allan. 1997. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30: 225-231.
117. Teather, L. A., M. G. Packard, and N. G. Bazan. 1998. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. Neurobiol. Learn. Mem. 70: 349-363.
118. Teather, L. A., M. G. Packard, and N. G. Bazan. 2001. Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. Neurobiol. Learn. Mem. 75: 310-324.
119. Chen, C., and N. G. Bazan. 1999. Platelet-activating factor inhibits ionotropic GABA receptor activity in cultured hippocampal neurons. Neuroreport. 10: 3831-3835.
120. Panetta, T., V. L. Marcheselli, P. Braquet, B. Spinnewyn, and N. G. Bazan. 1987. Effects of a platelet-activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood now in the gerbil brain: inhibition of ischemia reperfusion induced cerebral injury. Biochem. Biophys. Res. Commun. 149: 580-587.
121. Marcheselli, V. L., M. J. Rossowska, M. T. Domingo, P. Braquet, and N. G. Bazan. 1990. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265: 9140-9145.
122. Squinto, S. P., A. L. Block, P. Braquet, and N. G. Bazan. 1989. Platelet-activating factor stimulates a Fos/Jun/AP-1 transcriptional signaling system in human neuroblastoma cells. J. Neurosci. Res. 24: 558-566.
123. Squinto, S. P., P. Braquet, A. L. Block, and N. G. Bazan. 1990. Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes. J. Mol. Neurosci. 2: 79-84.
124. Bazan, N. G., S. P. Squinto, P. Braquet, T. Panetta, and V. L. Marcheselli. 1991. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a Fos/Jun/AP-1 transcriptional signaling system. Lipids. 26: 1236-1242.
125. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Toh, K. Ito, T. Miyamoto, and T. Shimizu. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349: 342-346.
126. Kunz, D., N. P. Gerard, and C. Gerard. 1992. The human leukocyte platelet-activating factor receptor. CDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J. Biol. Chem. 267: 9101-9106.
127. Sugimoto, T., H. Tsuchimochi, C. G. McGregor, H. Mutoh, T. Shimizu, and Y. Kurachi. 1992. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem. Biophys. Res. Commun. 189: 617-624.
128. Chen, C., J. C. Magee, V. L. Marcheselli, M. Hardy, and N. G. Bazan. 2001. Attenuated long-term potentiation in hippocampal dentate gyrus neurons of mice deficient in the platelet-activating factor receptor. J. Neurophysiol. 85: 384-390.
129. Kobayashi, K., S. Ishii, K. Kume, T. Takahasi, T. Shimizu, and T. Manabe. 1999. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region. Eur. J. Neurosci. 11: 1313-1316.
130. Ihida, K., D. Predescu, R-P. Czekay, and G. E. Palade. 1999. Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells. J. Cell Sci. 112: 285-295.
131. Marrache, A. M., F. Gobeil, Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, L. Fan, J-S. Joyal, J. G. Filep, D. R. Varma, A. Ribeiroda-Silva, and S. Chemtob. 2002. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol. 169: 6474-6481.
132. Bazan, N. G., B. S. Fletcher, H. R. Herschman, and P. K. Mukherjee. 1994. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc. Natl. Acad. Sci. USA. 91: 5252-5256.
133. Prehn, J. H. M., and J. Krieglstein. 1993. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J. Neurosci. Res. 34: 179-188.
134. Gilboe, D. D., D. Kintner, J. H. Fitzpatrick, S. E. Emoto, A. Esanu, P. G. Braquet, and N. G. Bazan. 1991. Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists. J. Neurochem. 56: 311-319.
135. Lindsberg, P. J., T-L. Yue, K. U. Frerichs, J. M. Hallenbeck, and G. Feuerstein. 1990. Evidence for platelet-activating factor as a novel mediator of experimental stroke in rabbits. Stroke. 21: 1452-1457.
136. Oberpichler, H., D. Sauer, C. Rossberg, H. D. Mennel, and J. Krieglstein. 1990. PAF antagonist ginkgolide-B reduces post-ischemic neuronal damage in rat brain hippocampus. J. Cereb. Blood Flow Metab. 10: 133-135.
137. Kochanek, P. M., A. J. Dutka, K. K. Kumaroo, and J. M. Hallenbeck. 1987. Platelet-activating factor receptor blockade enhances recovery after multi-focal brain ischemia. Life Sci. 41: 2639-2644.
138. Ogden, F., M. A. DeCoster, and N. G. Bazan. 1998. Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis. J. Neurosci. Res. 53: 677-684.
139. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. L. Trong, L. S. Cousens, G. A. Zimmerman, Y. Yamada, T. M. McIntyre, S. M. Prescott, and P. W. Gray. 1995. Anti-inflammatory, properties of a platelet-activating factor acetylhydrolase. Nature. 374: 549-553.
140. Han, X., and R. W. Gross. 2003. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44: 1071-1079.
141. Axelrod, J., R. M. Burch, and C. L. Jelsema. 1988. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11: 117-123.
142. Burch, R. M. 1989. G protein regulation of phospholipase A2. Mol. Neurobiol. 3: 155-171.
143. Dumuis, A., M. Sebben, L. Haynes, J. P. Pin, and J. Bockaert. 1988. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature. 336: 68-70.
144. Piomelli, D. 2003. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4: 873-884.
145. Carlson, G., Y. Wang, and B. E. Alger. 2003. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5: 723-724.
146. Minghetti, L., A. Greco, F. Cardone, M. Puopolo, A. Ladogana, and S. Almonti. 2000. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59: 866-871.
147. Minghetti, L., and G. Levi. 1998. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54: 99-125.
148. Fiebich, B. L., S. Schleicher, O. Spleiss, M. Czygan, and M. Hull. 2001. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 5: 950-958.
149. Kim, E. J., K. J. Kwon, J. Y. Park, S. H. Lee, C. H. Moon, and E. J. Baik. 2002. Neuroprotective effects of prostaglandin E2 of cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 70: 97-107.
150. Barres, B. A. 2003. What is a glial cell? Glia. 43: 4-5.
151. Hansson, E., and L. Rönnbäck. 2003. Glial neuronal signaling in the central nervous system. FASEB J. 17: 341-348.
152. Villegas, S. N., F. A. Poletta, and N. G. Carr. 2003. Glia: a reassessment based on novel data on the developing and mature central nervous system. Cell Biol. Int. 27: 599-609.